Skip to main content
. 2021 Mar 26;17:945–955. doi: 10.2147/NDT.S288108

Table 1.

Baseline Demographics and Clinical Characteristics

Total (N=518)
Age, years Mean (SD) 37.3 (11.2)
Sex, n (%) Female 288 (55.6)
Education status, n (%) University degree or higher 250 (48.3)
Up to and including junior college graduate level 268 (51.7)
Employment status, n (%) Employed/self-employed 437 (84.4)
Full-time 386 (88.3)a
Part-time 51 (11.7)a
Other (unemployed, student, etc.) 81 (15.6)
History of MDD episodes, n (%) First episode 310 (59.8)
Relapse 208 (40.2)
If relapsed, onset time of previous depressive episode, n (%) Within the last 12 months 39 (18.8)b
Earlier in life 169 (81.3)b
Time since onset of current depressive episode, n (%) <8 weeks 170 (32.8)
≥8 weeks 348 (67.2)
Antidepressant prescribed at baseline, n (%) Tricyclic 31 (6.0)
SSRI 209 (40.3)
SNRI 174 (33.6)
NaSSA 61 (11.8)
Other 43 (8.3)

Notes: aDenominator is 437 patients in paid employment or self-employed. Full-time was defined as working more than 32 hours per week. bDenominator is 208 patients with relapsed MDD. Adapted from J Affect Disord, Vol 258, Sumiyoshi T, Watanabe K, Noto S, et al. “Relationship of cognitive impairment with psychosocial function and relapse of depressive symptoms in patients with major depressive disorder: Analysis of longitudinal data from PERFORM-J”, 172–178, Copyright (2019), with permission from Elsevier.20

Abbreviations: MDD, major depressive disorder; NaSSA, noradrenergic and specific serotonergic antidepressant; SD, standard deviation; SNRI, serotonin–norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.